Table 2 Munivariate COX analysis for RFS in TNBC patients treated with radiotherapy from the METABRIC database.

From: PIPKIγ promotes non-homologous end joining through LIG4 to enhance radiotherapy resistance in triple-negative breast cancer

Covariate

Hazard ratio (95% CI)

P value

PIPKIγ

1.750 (1.018–3.009)

0.043

Tumor stage

Stage1 + Stage 2

Reference

 

Stage3

2.145 (1.142–4.031)

0.018

Back to article page